Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay L Zweier

Showing results (311-320 of 315) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 315 results.
Cell Metabolism|May 3, 2018
A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD<sup>+</sup> DeclineMariana G Tarragó, Claudia C S Chini, Karina S Kanamori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2019
Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded VesselsShahid M Nimjee, David Dornbos, George A Pitoc, et al.
Journal of the National Cancer Institute|May 17, 2023
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppressionJason V Evans, Shankar Suman, Mounika Uttam L Goruganthu, et al.
Nature Chemical Biology|November 17, 2009
Nitrate and nitrite in biology, nutrition and therapeuticsJon O Lundberg, Mark T Gladwin, Amrita Ahluwalia, et al.
EMBO Molecular Medicine|April 1, 2015
Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertensionKevin White, Yu Lu, Sofia Annis, et al.
Pageof 32

Showing results (311-320 of 315) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 315 results.
Cell Metabolism|May 3, 2018
A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD<sup>+</sup> DeclineMariana G Tarragó, Claudia C S Chini, Karina S Kanamori, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 17, 2019
Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded VesselsShahid M Nimjee, David Dornbos, George A Pitoc, et al.
Journal of the National Cancer Institute|May 17, 2023
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppressionJason V Evans, Shankar Suman, Mounika Uttam L Goruganthu, et al.
Nature Chemical Biology|November 17, 2009
Nitrate and nitrite in biology, nutrition and therapeuticsJon O Lundberg, Mark T Gladwin, Amrita Ahluwalia, et al.
EMBO Molecular Medicine|April 1, 2015
Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertensionKevin White, Yu Lu, Sofia Annis, et al.
Pageof 32